Press Releases

Search Press Releases
  
Subscribe for Email Alerts
10/10/2019
8:00 AM ET
Press Release

Mustang Bio Announces City of Hope Receives $4.1 Million in Grant Awards for Recently Opened First-of-Its-Kind Clinical Trial for Patients with Recurrent Malignant Glioma

10/10/2019

NEW YORK, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...

 Continue Reading
9/26/2019
8:30 AM ET
Press Release

Mustang Bio to Participate in October 2019 Investor Conferences

9/26/2019

NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...

 Continue Reading
9/23/2019
8:30 AM ET
Press Release

Mustang Bio Announces Phase 1 Clinical Trial Evaluating MB-105 for Prostate Stem Cell Antigen-Positive Castration-Resistant Prostate Cancer Enrolling Patients at City of Hope

9/23/2019

NEW YORK, Sept. 23, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...

 Continue Reading
9/9/2019
8:00 AM ET
Press Release

Mustang Bio to Present at Scientific Conferences in September 2019

9/9/2019

NEW YORK, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...

 Continue Reading
8/29/2019
8:00 AM ET
Press Release

Mustang Bio to Present at September 2019 Investor Conferences

8/29/2019

NEW YORK, Aug. 29, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and...

 Continue Reading
Displaying 1 to 5 (of 74 releases)